Biotech · Private company
Synermore Biologics Co., Ltd.
Track this companyFree. Adds Synermore Biologics Co., Ltd. to your Dealase workspace and tells you when its record changes.
Clinical trials30 recruiting or active
Pipeline programs9From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline9
- HRIG (HyperRab)Phase 2 · RabiesClinicalTrials.gov · fetched Nov 12, 2026
- HyperRAB ST (human rabies immune globulin)Phase 2 · Human RabiesClinicalTrials.gov · fetched Nov 12, 2026
- ImovaxPhase 2 · Human RabiesClinicalTrials.gov · fetched Nov 12, 2026
- RabAvertPhase 2 · Human RabiesClinicalTrials.gov · fetched Nov 12, 2026
- Rabies vaccinePhase 2 · RabiesClinicalTrials.gov · fetched Nov 12, 2026
- SYN023Phase 2 · Human RabiesClinicalTrials.gov · fetched Nov 12, 2026
- SYN023Phase 2 · RabiesClinicalTrials.gov · fetched Nov 12, 2026
- SYN004Phase 1 · Epithelial CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- SYN125Phase 1 · Epithelial CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- A Study to Find the MTD of SYN125 in People With Solid Tumors and the MTD of SYN125 With a Fixed Dose of SYN004 in People in Patients With Epithelial Cancers With EGFR ExpressionsPHASE1 · UNKNOWN · started Apr 9, 2020ClinicalTrials.gov NCT04363242 · fetched Nov 12, 2026
- Comparison of SYN023 to Human Rabies Immune Globulin in Post Exposure Prophylaxis of RabiesPHASE2 · COMPLETED · started Sep 3, 2019ClinicalTrials.gov NCT03961555 · fetched Nov 12, 2026
- A Comparison of the Safety, PD and PK of a Single Dose of SYN023 Administered With Licensed Rabies VaccinesPHASE1_PHASE2 · COMPLETED · started Aug 1, 2016ClinicalTrials.gov NCT02956746 · fetched Nov 12, 2026